The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Panel of Serum Biomarkers for the Diagnosis of Lung Cancer
Open accessAbstract
Purpose: Currently, a blood test for lung cancer does not exist. Serum biomarkers that could aid clinicians in making case management decisions would be enormously valuable. We used two proteomic platforms and a literature search to select candidate serum markers for the diagnosis of lung cancer. Methods: We initially assayed six serum proteins, four discovered by proteomics and two previously known to be cancer associated, on a training set of sera from 100 patients (50 with a new diagnosis of lung cancer and 50 age- and sex-matched controls). Classification and Regression Tree (CART) analysis selected a panel of four markers that most efficiently predicted which patients had lung cancer. An independent, blinded validation set of sera from 97 patients (49 lung cancer patients and 48 matched controls) determined the accuracy of the four markers to predict which patients had lung cancer. Results: Four serum proteins—carcinoembryonic antigen, retinol binding protein, α1-antitrypsin, and squamous cell carcinoma antigen—were collectively found to correctly classify the majority of lung cancer and control patients in the training set (sensitivity, 89.3%; specificity, 84.7%). These markers also accurately classified patients in the independent validation set (sensitivity, 77.8%; specificity, 75.4%). Remarkably, 90% of patients who fell into any one of three groupings in the CART analysis had lung cancer. Conclusion: This panel of four serum proteins is valuable in suggesting the diagnosis of lung cancer. These data may be useful for treating patients with an indeterminate pulmonary lesion, and potentially in predicting individuals at high risk for lung cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Cited by
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Cohen, J. D., Li, L., Wang, Y., Thoburn, C., Afsari, B., Danilova, L., Douville, C., Javed, A. A., Wong, F., Mattox, A., et al. (2018) · Science · doi:10.1126/science.aar3247 · Cited by 2,783
Herbst, R. S., Heymach, J. V., & Lippman, S. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0802714 · Cited by 2,389
Gold Nanoparticles for In Vitro Diagnostics
Zhou, W., Gao, X., Liu, D., & Chen, X. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00100 · Cited by 901
Kuzyk, M. A., Smith, D., Yang, J., Cross, T. J., Jackson, A. M., Hardie, D. B., Anderson, N. L., & Borchers, C. H. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800540-mcp200 · Cited by 515
Shin, H., Oh, S., Hong, S., Kang, M., Kang, D., Ji, Y.-G., Choi, B. H., Kang, K.-W., Jeong, H., Park, Y., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b09119 · Cited by 506
Metadata
- Authors
- Patz, E. F., Campa, M. J., Gottlin, E. B., Kusmartseva, I., Guan, X. R., & Herndon, J. E.
- Venue
- Journal of Clinical Oncology
- Published
- 2007-12-10
- Volume
- 25
- Issue
- 35
- Pages
- 5578-5583
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2115944658
- Cited by
- 247
- References
- 1
- FWCI
- 8.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Panel of Serum Biomarkers for the Diagnosis of Lung Cancer. https://app.cochat.ai/papers/10.1200/jco.2007.13.5392
- The paper
- Patz, E. F., Campa, M. J., Gottlin, E. B., Kusmartseva, I., Guan, X. R., & Herndon, J. E. (2007). Panel of Serum Biomarkers for the Diagnosis of Lung Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2007.13.5392
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.